Substance / Medication

Micafungin sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

7 trials linked to this intervention

7
Total Trials
0
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies.
De Rosa Francesco Giuseppe, Busca Alessandro, Capparella Maria Rita et al. · Clin Drug Investig · 2021
PMID: 33891293Meta-AnalysisFull text (PMC)
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Ikeda Fumiaki · Nihon Yakurigaku Zasshi · 2003
PMID: 14501170Observational
[Efficacy of micafungin sodium on fungal infection in critical care].
Tateishi Yoshihisa, Hirasawa Hiroyuki, Oda Shigeto et al. · Nihon Ishinkin Gakkai Zasshi · 2006
PMID: 17086162Review
Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.
Vehreschild Jörg J, Cornely Oliver A · Future Microbiol · 2006
PMID: 17661660Review
Micafungin sodium (FK-463).
Fromtling Robert A · Drugs Today (Barc) · 2002
PMID: 12532193Review
FTNIR Spectrometry of Micafungin Sodium Quality.
Isaacs James T, Almeter Philip J, Henderson Bradley S et al. · Contact Context · 2022
PMID: 35360460OtherFull text (PMC)
Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes.
Briot Thomas, Vrignaud Sandy, Lagarce Frédéric · Int J Pharm · 2015
PMID: 26187166Other
Visual compatibility of micafungin sodium and levofloxacin injections.
Fleischbein Eric, Montgomery Patricia A, Zhou Cindy S · Am J Health Syst Pharm · 2012
PMID: 23230033Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Micafungin sodium (substance)
SNOMED CT
426226002
UMLS CUI
C1576821

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
7
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.